Noncoding RNAs in breast cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recent advances in RNA sequencing technologies have unveiled the complexity of RNA world outdating the traditional view thatmany noncoding RNA (ncRNA) transcripts are transcriptional noise, while the protein coding genes are important players in cancer signaling. Accumulating evidence suggests that they are not only key regulators of gene expression, but also direct targets of cancer pathways. These aremainly classified according to their size: microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) being themost studied. The field has rapidly expanded and it is impossible to cover all the nuances in a single chapter. Noncoding RNAs, including miRNAs (~22 nucleotides long RNAs) and lncRNAs (>200 nucleotides), regulate gene expression at the transcriptional levels or post-transcriptionally by modulating the function of transcription factors, directing chromatin reorganization and modification, or by inhibiting the translation or stability of messenger RNA (mRNA).Here, we provide an overviewof the role of ncRNAs in breast cancer and their prognostic and predictive potential in the clinical practice.

Original languageEnglish (US)
Title of host publicationMolecular Pathology of Breast Cancer
PublisherSpringer International Publishing
Pages345-364
Number of pages20
ISBN (Electronic)9783319417615
ISBN (Print)9783319417592
DOIs
StatePublished - Jan 1 2016

Fingerprint

Long Noncoding RNA
Untranslated RNA
MicroRNAs
Nucleotides
RNA
Breast Neoplasms
RNA Sequence Analysis
Gene Expression
Regulator Genes
Chromatin
Noise
Neoplasms
Transcription Factors
Technology
Messenger RNA
Proteins

Keywords

  • Breast cancer
  • Gene regulation
  • Human genome and whole transcriptome
  • Long-noncoding RNA
  • Noncoding RNA
  • RNA-sequencing
  • Small RNA
  • Transcriptional noise

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Polar, Y., & Badve, S. (2016). Noncoding RNAs in breast cancer. In Molecular Pathology of Breast Cancer (pp. 345-364). Springer International Publishing. https://doi.org/10.1007/978-3-319-41761-5_22

Noncoding RNAs in breast cancer. / Polar, Yesim; Badve, Sunil.

Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. p. 345-364.

Research output: Chapter in Book/Report/Conference proceedingChapter

Polar, Y & Badve, S 2016, Noncoding RNAs in breast cancer. in Molecular Pathology of Breast Cancer. Springer International Publishing, pp. 345-364. https://doi.org/10.1007/978-3-319-41761-5_22
Polar Y, Badve S. Noncoding RNAs in breast cancer. In Molecular Pathology of Breast Cancer. Springer International Publishing. 2016. p. 345-364 https://doi.org/10.1007/978-3-319-41761-5_22
Polar, Yesim ; Badve, Sunil. / Noncoding RNAs in breast cancer. Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. pp. 345-364
@inbook{fa1108a9c678443e9121b2ed710cc39d,
title = "Noncoding RNAs in breast cancer",
abstract = "Recent advances in RNA sequencing technologies have unveiled the complexity of RNA world outdating the traditional view thatmany noncoding RNA (ncRNA) transcripts are transcriptional noise, while the protein coding genes are important players in cancer signaling. Accumulating evidence suggests that they are not only key regulators of gene expression, but also direct targets of cancer pathways. These aremainly classified according to their size: microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) being themost studied. The field has rapidly expanded and it is impossible to cover all the nuances in a single chapter. Noncoding RNAs, including miRNAs (~22 nucleotides long RNAs) and lncRNAs (>200 nucleotides), regulate gene expression at the transcriptional levels or post-transcriptionally by modulating the function of transcription factors, directing chromatin reorganization and modification, or by inhibiting the translation or stability of messenger RNA (mRNA).Here, we provide an overviewof the role of ncRNAs in breast cancer and their prognostic and predictive potential in the clinical practice.",
keywords = "Breast cancer, Gene regulation, Human genome and whole transcriptome, Long-noncoding RNA, Noncoding RNA, RNA-sequencing, Small RNA, Transcriptional noise",
author = "Yesim Polar and Sunil Badve",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-41761-5_22",
language = "English (US)",
isbn = "9783319417592",
pages = "345--364",
booktitle = "Molecular Pathology of Breast Cancer",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Noncoding RNAs in breast cancer

AU - Polar, Yesim

AU - Badve, Sunil

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Recent advances in RNA sequencing technologies have unveiled the complexity of RNA world outdating the traditional view thatmany noncoding RNA (ncRNA) transcripts are transcriptional noise, while the protein coding genes are important players in cancer signaling. Accumulating evidence suggests that they are not only key regulators of gene expression, but also direct targets of cancer pathways. These aremainly classified according to their size: microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) being themost studied. The field has rapidly expanded and it is impossible to cover all the nuances in a single chapter. Noncoding RNAs, including miRNAs (~22 nucleotides long RNAs) and lncRNAs (>200 nucleotides), regulate gene expression at the transcriptional levels or post-transcriptionally by modulating the function of transcription factors, directing chromatin reorganization and modification, or by inhibiting the translation or stability of messenger RNA (mRNA).Here, we provide an overviewof the role of ncRNAs in breast cancer and their prognostic and predictive potential in the clinical practice.

AB - Recent advances in RNA sequencing technologies have unveiled the complexity of RNA world outdating the traditional view thatmany noncoding RNA (ncRNA) transcripts are transcriptional noise, while the protein coding genes are important players in cancer signaling. Accumulating evidence suggests that they are not only key regulators of gene expression, but also direct targets of cancer pathways. These aremainly classified according to their size: microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) being themost studied. The field has rapidly expanded and it is impossible to cover all the nuances in a single chapter. Noncoding RNAs, including miRNAs (~22 nucleotides long RNAs) and lncRNAs (>200 nucleotides), regulate gene expression at the transcriptional levels or post-transcriptionally by modulating the function of transcription factors, directing chromatin reorganization and modification, or by inhibiting the translation or stability of messenger RNA (mRNA).Here, we provide an overviewof the role of ncRNAs in breast cancer and their prognostic and predictive potential in the clinical practice.

KW - Breast cancer

KW - Gene regulation

KW - Human genome and whole transcriptome

KW - Long-noncoding RNA

KW - Noncoding RNA

KW - RNA-sequencing

KW - Small RNA

KW - Transcriptional noise

UR - http://www.scopus.com/inward/record.url?scp=85009653917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009653917&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-41761-5_22

DO - 10.1007/978-3-319-41761-5_22

M3 - Chapter

AN - SCOPUS:85009653917

SN - 9783319417592

SP - 345

EP - 364

BT - Molecular Pathology of Breast Cancer

PB - Springer International Publishing

ER -